SCHEMBL797191

SCHEMBL797191

CCc1ccc[nH]c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL174911 0.85 KDM4E (0.44)
SCHEMBL10692239 0.81 DAO (0.41)
SCHEMBL5685566 0.81
SCHEMBL7240181 0.80 MAPT (0.45)
SCHEMBL2495417 0.80 GPR84 (0.46)
SCHEMBL1694688 0.79
SCHEMBL29743274 0.79
SCHEMBL217278 0.79
SCHEMBL6641176 0.79
SCHEMBL25582550 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023185306-A1 PPO2 POLYPEPTIDE HAVING TOLERANCE TO PPO INHIBITOR HERBICIDE AND APPLICATION 青岛清原化合物有限公司 2023-10-05 WO claimed
EP-3612522-A1 THERAPEUTIC COMPOUNDS Celgene Quanticel Research, Inc. (US) 2020-02-26 EP claimed
WO-2018195155-A1 THERAPEUTIC COMPOUNDS CELGENE QUANTICEL RESEARCH, INC. (US) 2018-10-25 WO claimed
WO-2025107145-A1 CONTINUOUS SYNTHESIS METHOD FOR DISPERSE YELLOW DYE 乐平市赛复乐医药化工有限公司 2025-05-30 WO disclosed
US-20240360081-A1 SULFONAMIDE OREXIN RECEPTOR AGONISTS AND USES THEREOF JAZZ PHARMACEUTICALS IRELAND LIMITED (IE) 2024-10-31 US disclosed
CN-116554705-B Continuous synthesis method of disperse yellow dye 乐平市赛复乐医药化工有限公司 2024-10-18 CN disclosed
WO-2024151833-A1 SPIRO DERIVATIVES AS M4 ACTIVATORS/MODULATORS AND USES THEREOF CEREVEL THERAPEUTICS, LLC (US) 2024-07-18 WO disclosed
US-20240239772-A1 PROTEASE INHIBITORS AND METHODS OF USE THE CLEVELAND CLINIC FOUNDATION 2024-07-18 US disclosed
CN-117769542-A Sulfonamide orexin receptor agonists and uses thereof 爵士制药爱尔兰有限公司 2024-03-26 CN disclosed
WO-2024027767-A1 HERBICIDE COMPOSITION COMPRISING URACIL COMPOUND COMPRISING CARBOXYLATE FRAGMENT AND USE OF HERBICIDE COMPOSITION 江苏中旗科技股份有限公司 2024-02-08 WO disclosed
US-11858957-B2 Ectonucleotidase inhibitors and methods of use thereof ANTENGENT THERAPEUTICS LIMITED (CN) 2024-01-02 US disclosed
US-20100204236-A1 Substituted imidazoles as bombesin receptor subtype-3 modulators MERCK SHARP & DOHME CORP. 2010-08-12 US disclosed
EP-2199284-A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID- BETA PROTEIN Sumitomo Chemical Company, Limited (JP) 2010-06-23 EP disclosed
US-20100028299-A1 Methods and compositions of treating a flaviviridae family viral infection THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2010-02-04 US disclosed
US-20090111822-A1 1,2,3-TRIAZOLE PYRROLIDINE DERIVATIVES AS MODULATORS OF MGLUR5 ASTRAZENECA AB (SE) 2009-04-30 US disclosed
WO-2009032124-A1 SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF SCHERING CORPORATION (US) 2009-03-12 WO disclosed
WO-2009032116-A1 2, 3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS SCHERING CORPORATION (US) 2009-03-12 WO disclosed
WO-2008082488-A1 4, 5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS SCHERING CORPORATION (US) 2008-07-10 WO disclosed
US-20070299065-A1 Tetrahydropyran Derivatives as Antidiabetics MERCK PATENT GMBH (DE) 2007-12-27 US disclosed
US-4008086-A PYRIDONE OR PYRIDAZONE DERIVATIVES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) 1977-02-15 US disclosed